Clinical

Articles

A new drug application has been filed for SOV2012-F1 (Kyzatrex) for the treatment of adult men with primary or secondary hypogonadism. 

FDA approval sought for novel oral testosterone replacement therapy for hypogonadism

Videos

Amarnath Rambhatla, MD, discusses findings from a study published online in the Journal of Sexual Medicine.

Testosterone therapy does not appear to worsen outcomes in men with COVID-19

Podcasts

Ramasamy talks about the findings of a recent study published in the Journal of Urology.

Speaking of Urology: Dr. Ranjith Ramasamy discusses nasal testosterone gel and sperm parameters

"The rigorous study and promising clinical availability of oral therapy for testosterone deficiency are flash points in the current era, in which the utility of testosterone therapy is under critical review," writes Arthur L. Burnett II, MD, MBA.

Oral testosterone agents mark important paradigm shift

Cheryl Guttman Krader is a contributor to Dermatology Times, Ophthalmology Times, and Urology Times.

Neither oral nor gel testosterones show significant effect on liver function test results.

QOL and body composition benefits seen with novel oral testosterone treatment

The treatment improves markers of nonalcoholic fatty liver disease, an investigator reports.

Novel oral testosterone therapy shows liver health benefits

Men whose activity exceeded guideline-based exercise levels experienced a decreased likelihood of lower serum testosterone, according to study results presented at the American Urological Association 2020 Virtual Experience.

Exceeding exercise guidelines may reduce likelihood of low T in men

"As we seek to understand MIST retreatment rates, as Houlihan and Köhler suggest, we must rely upon real-world population data," writes Gregg Eure, MD, in a letter to the editor.

Letter: BPH guidelines may ignore FDA, insurance criteria

Interim results from a clinical trial of a next-generation penile traction therapy device were encouraging and demonstrated statistically significant increases in penile length and a smaller reduction in erectile function among post-prostatectomy men who were treated with the device, known as RestoreX, according to PathRight Medical.

Penile traction device shows benefit in men post-radical prostatectomy

Kevin McVary, MD, of Loyola University Medical Center in Maywood, IL, provides urologists with tips on how to assess the adoptability of minimally invasive surgical therapies for BPH.

Men's Health